logo

For the Inventor, By the Inventor

Redwood City, CA, United States of America

Maxygen, Inc.


USPTO Granted Patents = 124

% Expired Patents = 28.2



Forward Citations = 17,265

Loading Chart...
Loading Chart...

98 inventors (with patents filed for the assignee):

goldMedal Willem P C Stemmer (70 out of 90 patents)

silverMedal Phillip A Patten (54 out of 100 patents)

bronzeMedal Jeremy S Minshull (38 out of 126 patents)

4.  Jon Edward Ness (20 out of 42 patents)

5.  Claes Gustafsson (19 out of 44 patents)

6.  Matthew B Tobin (16 out of 24 patents)

7.  Steven Henry Bass (15 out of 31 patents)

8.  Torben Lauesgaard Nissen (13 out of 19 patents)

9.  Mark D Welch (13 out of 40 patents)

10.  Andreas Crameri (12 out of 23 patents)

11.  Sridhar Viswanathan (12 out of 13 patents)

12.  Sridhar Govindarajan (11 out of 39 patents)

13.  Linda A Castle (10 out of 39 patents)

14.  Juha Punnonen (10 out of 30 patents)

15.  Lorraine Joan Giver (8 out of 42 patents)


Core Competencies:
Antibody Diversity
Polypeptide Engineering
Cellular Engineering
Metabolic Engineering
Cytokine Polypeptides
Recombination
DNA Shuffling
Oligonucleotide Libraries
Evolved Variants
Co-Stimulatory Molecules
High Throughput Screening
Genetic Vaccines

124 patents:

1. 8252727 - Antibody diversity generation (2012-08-28),
2. 7795030 - Methods and compositions for cellular and metabolic engineering (2010-09-14),
3. 7783428 - Methods, systems, and software for identifying functional biomolecules (2010-08-24),
4. 7776598 - Methods and compositions for polypeptide engineering (2010-08-17),
5. 7751986 - Methods, systems, and software for identifying functional biomolecules (2010-07-06),
6. 7747393 - Methods, systems, and software for identifying functional biomolecules (2010-06-29),
7. 7747391 - Methods, systems, and software for identifying functional biomolecules (2010-06-29),
8. 7702464 - Method and apparatus for codon determining (2010-04-20),
9. 7696153 - G-CSF conjugates (2010-04-13),
10. 7629170 - Evolution of whole cells and organisms by recursive sequence recombination (2009-12-08),
11. 7620502 - Methods for identifying sets of oligonucleotides for use in an in vitro recombination procedure (2009-11-17),
12. 7620500 - Optimization of crossover points for directed evolution (2009-11-17),
13. 7619067 - Evolved interferon-alpha polypeptides (2009-11-17),
14. 7612170 - Co-stimulatory polypeptides (2009-11-03),
15. 7605115 - Subtilisin variants (2009-10-20),
Company Overview
Maxygen, Inc., based in Redwood City, California, specializes in polypeptide engineering, focusing on the development of innovative biopharmaceuticals. The company leverages advanced techniques in antibody diversity, cellular and metabolic engineering, and cytokine polypeptides to create novel therapeutic solutions. With a strong emphasis on recombination and DNA shuffling, Maxygen aims to enhance the efficacy and specificity of biologics, contributing to advancements in the biotechnology sector and improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Maxygen, Inc. USPTO Patent Assignee Logo
124 Patents

#20 in Redwood City, CA

#708 in California

#3,132 in US

#6,471 in the World

Redwood City, CA (US)
Redwood City, CA, United States of America

Maxygen, Inc.

Forward Citations = 17,265

98 inventors:

goldMedal Willem P C Stemmer (70 out of 90 patents)

silverMedal Phillip A Patten (54 out of 100 patents)

bronzeMedal Jeremy S Minshull (38 out of 126 patents)

4.  Jon Edward Ness (20 out of 42 patents)

5.  Claes Gustafsson (19 out of 44 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Maxygen, Inc.. Retrieved from https://idiyas.com/company/maxygen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…